China Isotope & Radiation Corporation Partners with Peruvian Agricultural Enterprise for First Gamma Irradiation Facility in Peru

Reuters
06 Jun
China Isotope & Radiation Corporation Partners with Peruvian Agricultural Enterprise for First Gamma Irradiation Facility in Peru

China Isotope & Radiation Corporation $(CIRC.UK)$ has announced its first irradiation station cooperation project in Peru, marking a significant milestone in its expansion into Latin America. The Beijing branch of CIRC has entered into a purchase intention contract with a renowned Peruvian agricultural enterprise based in Lima. This collaboration involves the construction of a gamma irradiation facility designed to have a loading capacity of 1 million curies, aimed at preserving organic fruits and vegetables to enhance their shelf life and improve export efficiency. The project fills a gap in irradiation application in Peru and is expected to be the first commercial gamma irradiation facility in the country. This initiative is part of the Belt and Road Initiative, fostering deeper exchanges and cooperation between China and Peru in nuclear technology and agriculture.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Isotope & Radiation Corporation published the original content used to generate this news brief on June 06, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10